Variant report
Variant | nsv589939 |
---|---|
Chromosome Location | chr3:22275178-22286262 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28648055 | chr3:22275178-22275179 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs536771170 | chr3:22275202-22275203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75113399 | chr3:22275314-22275315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371300470 | chr3:22275321-22275322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541842996 | chr3:22275333-22275334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs375592305 | chr3:22275364-22275365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563407893 | chr3:22275422-22275423 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145584384 | chr3:22275439-22275440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs530941494 | chr3:22275449-22275450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs150213088 | chr3:22275484-22275485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1388548 | chr3:22275487-22275488 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs183130883 | chr3:22275507-22275508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551185496 | chr3:22275521-22275522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188219414 | chr3:22275553-22275554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs116681572 | chr3:22275566-22275567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192327577 | chr3:22275578-22275579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116916931 | chr3:22275613-22275614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184348936 | chr3:22275616-22275617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149400706 | chr3:22275637-22275638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566505762 | chr3:22275638-22275639 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533994220 | chr3:22275662-22275663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs555343625 | chr3:22275675-22275676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144762978 | chr3:22275710-22275711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577900929 | chr3:22275747-22275748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372625731 | chr3:22275751-22275752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs187928285 | chr3:22275762-22275763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556982937 | chr3:22275764-22275765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548971596 | chr3:22275774-22275775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575326524 | chr3:22275796-22275797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192405465 | chr3:22275810-22275811 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184562479 | chr3:22275817-22275818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540520595 | chr3:22275829-22275830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138481701 | chr3:22275840-22275841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562232694 | chr3:22275841-22275842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71620747 | chr3:22275847-22275848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529644012 | chr3:22275858-22275859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550588843 | chr3:22275874-22275875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562506341 | chr3:22275882-22275883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532964453 | chr3:22275956-22275957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs375160152 | chr3:22275958-22275959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551141286 | chr3:22275961-22275962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79148486 | chr3:22275975-22275976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573538138 | chr3:22275977-22275978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533713115 | chr3:22275987-22275988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs117985694 | chr3:22275988-22275989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567220348 | chr3:22276008-22276009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189288447 | chr3:22276033-22276034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74653741 | chr3:22276050-22276051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs556050079 | chr3:22276100-22276101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575194389 | chr3:22276124-22276125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22268000-22278400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr3:22278200-22278400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr3:22278400-22278800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr3:22278400-22279200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr3:22278800-22280400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr3:22279200-22280400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr3:22280400-22280800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr3:22280600-22280800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr3:22284600-22286200 | Weak transcription | NHDF-Ad | bronchial |
10 | chr3:22285600-22287400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
11 | chr3:22286000-22287600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr3:22286200-22286800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
13 | chr3:22286200-22287600 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr3:22286200-22287600 | Enhancers | Fetal Stomach | stomach |
15 | chr3:22286200-22287600 | Enhancers | HMEC | breast |
16 | chr3:22286200-22287600 | Enhancers | NHDF-Ad | bronchial |
17 | chr3:22286200-22287600 | Enhancers | NHLF | lung |
18 | chr3:22286200-22288000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr3:22286200-22288000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |